Latest Tumor markers Stories
BRCA Share(TM) is a novel public-private initiative designed to enhance the clarity and quality of patient testing MADISON, N.J.
-- 300 patient US pilot study shows MiCheck(TM) test has 85% specificity - compared to 40% for existing PSA technology SYDNEY, April 20, 2015 /PRNewswire/ -- A NEW
A landmark DNA study in Iceland has resulted in an unprecedented look at an entire country’s genetic makeup, discovering several previously unknown mutations that could cause a vast array of different health problems, but regulations prevent some of that data from being used.
A magnetic resonance spectroscopy technique that monitors biochemical changes in tissue could improve the management of women at risk of breast cancer, according to a new study published online,
Goal of Enabling Affordable, Large-Scale BRCA1 and BRCA2 Screening for General Population FREMONT, Calif., Feb. 19, 2015 /PRNewswire/ -- WaferGen Bio-systems, Inc.
Agreement ensures continuing broad patient access to Quest's BRCAvantage(TM) services for evaluating genetic risk of developing breast, ovarian and other cancers MADISON, N.J., Feb.
-- Findings could lead to new therapies for breast, ovarian, and other cancers NEW YORK, Feb.
A team of UK researchers led by Oxford University scientists has devised a new test that could help doctors diagnose breast cancer earlier by detecting changes in a person’s zinc levels.
An ExitCoachRadio.com story about how two long time friends and musicians are joining together to beat cancer in more ways than one. (PRWEB) November 19, 2014
- An armed gangster.